CGTAAVLimited DatastaleJanssen Research & Development,…Phase 3
Genetic: AAV5-hRKp.RPGR Intermediate Dose (Genetic: AAV5-hRKp.RPGR Intermediate Dose)
X-Linked Retinitis Pigmentosa · X-Linked Retinitis Pigmentosa
#X-LinkedRetinitisPigmentosa#CGT#Phase3#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting